Target intelligence / Profile preview

Exo-1,3-beta-glucan glucohydrolase (Exo-I) (Exo-I)

Target
Exo-I
Molecular classification
Enzyme, Glycosyl hydrolase family 3
01

Overview

Exo-1,3-beta-glucan glucohydrolase is a plant enzyme found in barley (Hordeum vulgare) that belongs to the glycosyl hydrolase family 3 (GH3) [1]. Its primary biological role is the hydrolysis of (1->3)-beta-D-glucans, which are major components of plant cell walls and fungal cell walls [3]. During barley germination, this enzyme facilitates the mobilization of energy reserves by breaking down cell wall polysaccharides into glucose [2]. Additionally, it serves as a pathogenesis-related (PR) protein, contributing to the plant's defense against fungal infections by degrading the fungal cell wall [1]. While it is not a target for human therapeutic drugs, it is of significant interest in the brewing and malting industries for its role in cell wall degradation [2]. The enzyme's structure and mechanism have been extensively studied to understand carbohydrate-protein interactions and enzymatic catalysis, particularly its interaction with transition-state analogs like isofagomine [2].

Other names
Barley exo-1,3-beta-glucanase1,3-beta-D-glucan glucohydrolaseExo-beta-glucanaseExo-1,3-beta-glucanaseExo-II
02

Mechanism of action

The enzyme catalyzes the hydrolysis of terminal non-reducing (1->3)-beta-D-glucosidic linkages in (1->3)-beta-D-glucans, releasing beta-D-glucose via a retaining mechanism involving two glutamic acid residues acting as a nucleophile and an acid/base catalyst [1][2].

03

Biological functions

Carbohydrate metabolismCell wall degradationPlant defense
04

Safety considerations

Potential allergenicity in industrial settings (e.g., baker's asthma)

Beyond the preview

Go deeper on Exo-1,3-beta-glucan glucohydrolase (Exo-I) (Exo-I).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Exo-1,3-beta-glucan glucohydrolase (Exo-I) (Exo-I).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call